A shorter course for anti-relapse therapy against vivax malaria


A new study suggests that cutting the duration of a course in therapy to 7 days instead of 14 days and to increasing the dosage in that time period will improve patient participation to full term in anti-relapse therapy for malaria. 

Content Information

Content Author: 
Philip Rosenthal
Content Source: 
Lancet
Content Type: 
News